| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/20/2006 | CN1275980C Method of modifying microorganism-origin transglutaminase |
| 09/19/2006 | US7109404 Selfing, backcrosses, hybrid production, and crosses to populations to produce hybrid seeds and plants with superior characteristics, such as herbicide resistance, insect resistance, modified fatty acid metabolism, modified carbohydrate metabolism, and resistance to bacterial, fungal or viral disease |
| 09/19/2006 | US7109402 Potato cultivar FL 2072 |
| 09/19/2006 | US7109401 Potato cultivar FL 2053 |
| 09/19/2006 | US7109400 Transgenic seeds for use in generation and propagation of disease, heat, freeze, insect and herbicide resistant plants; tissue engineering |
| 09/19/2006 | US7109399 Soybean cultivar 0491735 |
| 09/19/2006 | US7109397 Comprises nucleotide sequences coding hypersensitive response elicitor protein (HREP) for conferring improved ripening, flowering, longevity and disease, stress and dessication resistance to plants; biological pest control |
| 09/19/2006 | US7109396 Preparing transgenic corn with increased concentrations of sulfur containing compounds for improving animal feeds and viability of maize |
| 09/19/2006 | US7109395 Prevention of the dispersal of seeds through the process of dehiscence (pod shattering), which leads to significant seed loss during harvesting of crops |
| 09/19/2006 | US7109394 Methods for modulating floral organ identity, modulating floral organ number, increasing of meristem size, and delaying flowering time |
| 09/19/2006 | US7109393 Methods of gene silencing using inverted repeat sequences |
| 09/19/2006 | US7109392 Methods for increasing oleic acid content in seeds from transgenic plants containing a mutant delta 12 desaturase |
| 09/19/2006 | US7109391 Plant farnesyltransferases |
| 09/19/2006 | US7109390 Modulating gene expression in crop plants and transforming crop plants that display low transformation efficiencies with existing transformation methods |
| 09/19/2006 | US7109322 Process for the depletion or removal of endotoxins |
| 09/19/2006 | US7109321 Of given sequence; has promoter activity thus enabling genetic manipulation |
| 09/19/2006 | US7109320 Nucleic acid molecules encoding human tumor necrosis factor α-specific antibodies |
| 09/19/2006 | US7109319 For treatment of auto-immune and immunde disorders and chronic obstructive pulmonary disease; FAIL is an Fc receptor |
| 09/19/2006 | US7109318 Nucleic acids encoding PRO830 |
| 09/19/2006 | US7109317 Recombinant nucleic acid encoding a composite protein, including a CAB domain with a portion of calcineurin A and a portion of calcineurin B, forming a tripartite complex with an FKBP/CAB ligand and an FKBP domain; gene transcription or activation of an intracellular signal transduction pathway |
| 09/19/2006 | US7109316 New class of nucleoside triphosphates that contain an oligonucleotide of random or defined sequence attached to the base and are substrates for polymerases and terminal nucleotidyl transferases is described |
| 09/19/2006 | US7109314 Fluorescent nucleotides |
| 09/19/2006 | US7109307 Nucleotide sequences coding polypeptide for use in the treatent of inflammatory disorders |
| 09/19/2006 | US7109306 Antibody or fragment that specifically binds to a protein, decrease in the level of mim-1 protein is observed; inhibiting abnormal cell proliferation or differentiation |
| 09/19/2006 | US7109301 Tenascin-C isoform as marker for neoplasias |
| 09/19/2006 | US7109296 Used to identify modulators of the 5-HT3 serotonin receptor complex, and to reconstitute a more realistic physiological 5-HT3 receptor response in recombinant systems |
| 09/19/2006 | US7109295 Fusion polypeptide (chimera); a zinc finger (ZF) monomer, e.g., a Cys2His2 zinc finger protein, that recognizes a DNA sequence, a dimerization domain of a tetracycline repressor, containing a drug-dependent switch, and an accessory domain to alter the expression of the target gene |
| 09/19/2006 | US7109293 System for detecting protease |
| 09/19/2006 | US7109179 Methods and compositions comprising DNA damaging agents and p53 |
| 09/19/2006 | US7109178 Method for ligating nucleic acids and molecular cloning |
| 09/19/2006 | US7109167 Tetrapeptide |
| 09/19/2006 | US7109160 Peptides containing the motif IGD and their use as cell migration modulators |
| 09/19/2006 | US7109033 Methods of identifying an agent that modulates the activity of a plant stress-regulated regulatory element, and methods of determining whether a plant has been exposed to a stress |
| 09/19/2006 | US7109030 Anticarcinogenic, antiproliferative agents; drug screening, receptor binding assay |
| 09/19/2006 | US7109029 Adenoviral transcription of colony stimulating factor; gene expression inhibition; antitumor agents; antiproliferative agents; tissue engineering |
| 09/19/2006 | US7109027 Aβ-Peptide screening assay |
| 09/19/2006 | US7109026 Use of MHC class II ligands as adjuvant for vaccination and of LAG-3 in cancer treatment |
| 09/19/2006 | US7109025 Viral vectors and viral vaccines based on recombinant porcine adenoviruses |
| 09/19/2006 | US7109021 Can be used for the treatment of diabetes or for delaying the onset of diabetes |
| 09/19/2006 | US7109020 Leguminous bacterium having potentiated nitrogen fixation ability |
| 09/19/2006 | US7109019 Gene cluster for production of the enediyne antitumor antibiotic C-1027 |
| 09/19/2006 | US7109018 Transformant producing secondary metabolite modified with functional group and novel biosynthesis genes |
| 09/19/2006 | US7109016 Genetically engineered substilisin for use as degratory agent in cleaning or laundering detergent |
| 09/19/2006 | US7109015 Capable of removing the N-terminal Met from bulky or acidic penultimate residues |
| 09/19/2006 | US7109014 Diglycosidase isolated from microorganisms |
| 09/19/2006 | US7109013 Cellulase preparation containing nonionic surfactant and method of treating fiber |
| 09/19/2006 | US7109012 Recombinant lysophosphatidic acid phosphatase |
| 09/19/2006 | US7109011 Nucleotide sequences coding polypeptide for use in the treatment of infections, pneumonia, toxic shock, brain and rheumatic diseases |
| 09/19/2006 | US7109010 Isolated nucleic acid encoding a yeast lactate dehydrogenate protein; use in production of lactic acid |
| 09/19/2006 | US7109009 Comprises nucleotide sequences coding enzymatic polypeptide for producing intermediates associated with thermoplastics, plasticizing agents, lubricants, hydraulic fluids, dyes, agricultural hemicals, pharmaceuticals and adhesives |
| 09/19/2006 | US7109008 L-glutamate oxidase |
| 09/19/2006 | US7109007 Polyhydroxybutyrate polymerase |
| 09/19/2006 | US7109006 Virulence of Streptococci |
| 09/19/2006 | US7109002 obtained by recombinant expression of DNA of human herpes virus type 8, and which may be used in diagnosis and treatment of human diseases such as kaposi sarcoma, Castleman's disease, multiple myeloma, kidney cell carcinoma, mesangial proliferative glomerulonephritis or B cell lymphoma |
| 09/19/2006 | US7109001 COBRA gene and uses thereof |
| 09/19/2006 | US7108999 Nucleotide sequences coding protein for use in treating eating disorder, autoimmune and viral diseases |
| 09/19/2006 | US7108998 Nucleic acid fragment encoding an NRPS for the biosynthesis of anthramycin |
| 09/19/2006 | US7108994 Identifying a compound that modulates phosphotyrosine phosphatase activity of a polypeptide by incuabating togetjer and measuring activity of enzyme |
| 09/19/2006 | US7108991 Receptors whose endogenous ligand has not been identified (orphan) |
| 09/19/2006 | US7108989 Therapy |
| 09/19/2006 | US7108977 Process for determining the tumoricidal potential of a sample the use of a nucleic acid which is downregulated in human tumor cells |
| 09/19/2006 | US7108975 Atlastin |
| 09/19/2006 | US7108974 Detecting bacteria or viral nucleotide sequences; restriction fragment length polymorphism; fourier transform ion cyclotron resonance mass spectrometry (FT-ICR-MS); ion trap; time of flight |
| 09/19/2006 | US7108972 Proteins, polynucleotides encoding them and methods of using the same |
| 09/19/2006 | US7108858 Immunological protein |
| 09/19/2006 | US7108856 Comprise viral amino acid sequences for use in vaccine preparation and prevention of viral infection |
| 09/19/2006 | US7108850 Polypeptides of an IL-1-like cytokine |
| 09/19/2006 | CA2308117C Novel nucleic acid sequence encoding flp recombinase |
| 09/19/2006 | CA2248186C Compounds related to the amidinium family, pharmaceutical compositions containing same, and uses thereof |
| 09/19/2006 | CA2235269C Monoclonal antibody br110 and uses thereof |
| 09/19/2006 | CA2083396C Derivatives of human bile-salt stimulated lipase, and pharmaceutical compositions containing them |
| 09/19/2006 | CA2074854C Imidazolinone resistant ahas mutants |
| 09/18/2006 | CA2501301A1 Human endogenous foamy retrovirus and uses thereof |
| 09/14/2006 | WO2006096459A2 Infectious, chimeric hepatitis c virus, methods of producing the same and methods of use thereof |
| 09/14/2006 | WO2006096441A2 Reagents, methods and systems to suppress phospholamban expression |
| 09/14/2006 | WO2006096269A2 Targeted gene deletions for polysaccharide slime formers |
| 09/14/2006 | WO2006096222A2 Nucleic acid ligands specific to immunoglobulin e and their use as atopic disease therapeutics |
| 09/14/2006 | WO2006096130A1 Arabinose- and xylose-fermenting saccharomyces cerevisiae strains |
| 09/14/2006 | WO2006096063A1 Construct and method for screening, selection and identification of stress factors |
| 09/14/2006 | WO2006096018A1 Small interfering rna and pharmaceutical composition for treatment of hepatitis b comprising the same |
| 09/14/2006 | WO2006095981A1 Processes using dual specificity oligonucleotide and dual specificity oligonucleotide |
| 09/14/2006 | WO2006095941A1 Processes using dual specificity oligonucleotide and dual specificity oligonucleotide |
| 09/14/2006 | WO2006095846A1 Model animal in which state of disease condition is observable in real time, gene construct for achieving the same and use of the same |
| 09/14/2006 | WO2006095831A1 Probe and carrier having probe immobilized thereon |
| 09/14/2006 | WO2006095830A1 Linker compound, probe, and carrier having probe immobilized thereon |
| 09/14/2006 | WO2006095769A1 Microorganism-derived psychrophilic endonuclease |
| 09/14/2006 | WO2006095749A1 Method for expression and accumulation of peptide in plant |
| 09/14/2006 | WO2006095731A1 CRYSTAL OF COMPLEX OF Rho-KINASE AND SUBSTANCE CAPABLE OF INTERACTING WITH Rho-KINASE |
| 09/14/2006 | WO2006095654A1 Reporter gene assay method |
| 09/14/2006 | WO2006095559A1 USE OF Fgf21 AS HEMATOPOIETIC FACTOR |
| 09/14/2006 | WO2006095550A1 Pcr primer, pcr method utilizing the same, and pcr amplified product, and device and dna-protein complex utilizing pcr amplified product |
| 09/14/2006 | WO2006095474A1 Method for production of compound containing unnatural amino acid and/or hydroxy acid |
| 09/14/2006 | WO2006095195A1 Antimicrobial compounds |
| 09/14/2006 | WO2006095156A1 Vectors comprising novel regulatory elements |
| 09/14/2006 | WO2006095034A1 Parthenocarpic tomatoes and production method thereof |
| 09/14/2006 | WO2006094976A2 Expression enhancing intron sequences |
| 09/14/2006 | WO2006094813A2 Dimeric or multimeric microproteins |
| 09/14/2006 | WO2006094805A1 Photoproteins with enhanced bioluminescence and their use as intracellular calcium indicators |
| 09/14/2006 | WO2006094406A1 Antisense oligonucleotides targeted to the coding region of thymidylate synthase and uses thereof |
| 09/14/2006 | WO2006094360A1 Method of amplifying nucleic acid |